These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 12823147

  • 1. Remission maintenance by tioguanine in chronic active Crohn's disease.
    Herrlinger KR, Deibert P, Schwab M, Kreisel W, Fischer C, Fellermann K, Stange EF.
    Aliment Pharmacol Ther; 2003 Jun 15; 17(12):1459-64. PubMed ID: 12823147
    [Abstract] [Full Text] [Related]

  • 2. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 3. Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.
    Herrlinger KR, Fellermann K, Fischer C, Kreisel W, Deibert P, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Greinwald R, Stange EF, Schwab M.
    Aliment Pharmacol Ther; 2004 Jun 15; 19(12):1269-76. PubMed ID: 15191508
    [Abstract] [Full Text] [Related]

  • 4. 6-thioguanine--efficacy and safety in chronic active Crohn's disease.
    Herrlinger KR, Kreisel W, Schwab M, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Deibert P, Fellermann K, Greinwald R, Stange EF.
    Aliment Pharmacol Ther; 2003 Feb 15; 17(4):503-8. PubMed ID: 12622758
    [Abstract] [Full Text] [Related]

  • 5. High variation of tioguanine absorption in patients with chronic active Crohn's disease.
    Deibert P, Dilger K, Fischer C, Hofmann U, Nauck S, Stoelben S, Kreisel W.
    Aliment Pharmacol Ther; 2003 Jul 15; 18(2):183-9. PubMed ID: 12869078
    [Abstract] [Full Text] [Related]

  • 6. Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies.
    Simsek M, Deben DS, Horjus CS, Bénard MV, Lissenberg-Witte BI, Buiter HJC, van Luin M, Seinen ML, Mulder CJJ, Wong DR, de Boer NKH, van Bodegraven AA.
    Aliment Pharmacol Ther; 2019 Jul 15; 50(1):54-65. PubMed ID: 31094013
    [Abstract] [Full Text] [Related]

  • 7. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.
    Bonaz B, Boitard J, Marteau P, Lémann M, Coffin B, Flourié B, Belaiche J, Cadiot G, Metman EH, Cortot A, Colombel JF, Getaid.
    Aliment Pharmacol Ther; 2003 Aug 15; 18(4):401-8. PubMed ID: 12940925
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598
    [Abstract] [Full Text] [Related]

  • 9. 6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients.
    Almer SH, Hjortswang H, Hindorf U.
    Dig Liver Dis; 2009 Mar 12; 41(3):194-200. PubMed ID: 18799369
    [Abstract] [Full Text] [Related]

  • 10. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study.
    Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G.
    Dig Liver Dis; 2003 Sep 12; 35(9):619-27. PubMed ID: 14563183
    [Abstract] [Full Text] [Related]

  • 11. Further experience with the use of 6-thioguanine in patients with Crohn's disease.
    Ansari A, Elliott T, Fong F, Arenas-Hernandez M, Rottenberg G, Portmann B, Lucas S, Marinaki A, Sanderson J.
    Inflamm Bowel Dis; 2008 Oct 12; 14(10):1399-405. PubMed ID: 18521912
    [Abstract] [Full Text] [Related]

  • 12. Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn's Disease.
    Savelkoul EHJ, Maas MHJ, Bourgonje AR, Crouwel F, Biemans VBC, den Broeder N, Russel MGVM, Römkens TEH, de Boer NK, Dijkstra G, Hoentjen F.
    J Crohns Colitis; 2022 Sep 08; 16(9):1372-1379. PubMed ID: 35303065
    [Abstract] [Full Text] [Related]

  • 13. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
    Sandborn WJ, Tremaine WJ, Wolf DC, Targan SR, Sninsky CA, Sutherland LR, Hanauer SB, McDonald JW, Feagan BG, Fedorak RN, Isaacs KL, Pike MG, Mays DC, Lipsky JJ, Gordon S, Kleoudis CS, Murdock RH.
    Gastroenterology; 1999 Sep 08; 117(3):527-35. PubMed ID: 10464128
    [Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW, Bickston SJ.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD006893. PubMed ID: 18254120
    [Abstract] [Full Text] [Related]

  • 15. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease].
    Kull E, Beau P.
    Gastroenterol Clin Biol; 2002 Apr 23; 26(4):367-71. PubMed ID: 12070412
    [Abstract] [Full Text] [Related]

  • 16. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA, McDonald JW, Feagan BG.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD003459. PubMed ID: 15674908
    [Abstract] [Full Text] [Related]

  • 17. [Anti-TNF therapy in treatment of luminal Crohn's disease].
    Marko B, Prka L.
    Acta Med Croatica; 2013 Apr 25; 67(2):179-89. PubMed ID: 24471301
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA, McDonald JW, Feagan BG.
    Cochrane Database Syst Rev; 2003 Apr 25; (1):CD003459. PubMed ID: 12535475
    [Abstract] [Full Text] [Related]

  • 19. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C, Wittig BM, Moser C, Zeitz M, Stallmach A.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):343-50. PubMed ID: 16842461
    [Abstract] [Full Text] [Related]

  • 20. Natalizumab for induction of remission in Crohn's disease.
    MacDonald JK, McDonald JW.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD006097. PubMed ID: 17253580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.